Jama Pitman Deciphera Pharmaceuticals, Inc. (DCPH) insider trading activity

Jama Pitman is SVP, Chief Development Officer of Deciphera Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of DCPH, which is worth approximately $0. The most recent transaction as insider was on Jun 11, 2024, when has been sold 53,951 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Jama Pitman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 11 2024	SELL Sale (or disposition) back to the issuer	-	53,951 Reduced 61.17%	34,243 Common Stock
Jun 11 2024	SELL Disposition due to a tender of shares in a change of control transaction	-	34,243 Reduced 100.0%	0 Common Stock
Jun 11 2024	BUY Grant, award, or other acquisition	-	20,163 Added 18.61%	88,194 Common Stock
Feb 16 2024	SELL Open market or private sale	$35,410 $15.62 p/Share	2,267 Reduced 3.22%	68,031 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	19,725 Added 21.91%	70,298 Common Stock
Jan 16 2024	SELL Open market or private sale	$23,499 $14.47 p/Share	1,624 Reduced 3.11%	50,573 Common Stock
Dec 13 2023	SELL Open market or private sale	$25,544 $15.37 p/Share	1,662 Reduced 3.09%	52,197 Common Stock
Dec 12 2023	BUY Grant, award, or other acquisition	-	5,576 Added 9.38%	53,859 Common Stock
Oct 30 2023	SELL Open market or private sale	$16,912 $12.02 p/Share	1,407 Reduced 2.83%	48,283 Common Stock
Oct 28 2023	BUY Grant, award, or other acquisition	-	5,576 Added 10.09%	49,690 Common Stock
Jun 16 2023	SELL Open market or private sale	$17,827 $14.4 p/Share	1,238 Reduced 2.75%	43,812 Common Stock
Feb 16 2023	SELL Open market or private sale	$17,500 $15.1 p/Share	1,159 Reduced 2.51%	45,050 Common Stock
Feb 15 2023	BUY Grant, award, or other acquisition	-	11,151 Added 19.44%	46,209 Common Stock
Jan 17 2023	SELL Open market or private sale	$34,047 $21.24 p/Share	1,603 Reduced 4.37%	35,058 Common Stock
Jun 16 2022	SELL Open market or private sale	$13,954 $10.75 p/Share	1,298 Reduced 3.42%	36,661 Common Stock
Feb 16 2022	SELL Open market or private sale	$10,371 $9.05 p/Share	1,146 Reduced 2.93%	37,959 Common Stock
Jan 18 2022	BUY Grant, award, or other acquisition	-	13,667 Added 25.9%	39,105 Common Stock
Dec 15 2021	BUY Grant, award, or other acquisition	-	8,300 Added 24.6%	25,438 Common Stock

Jama Pitman

SVP, Chief Development Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DCPH shares.

Notify only if

Value

Insider Trading

Get notified when an Deciphera Pharmaceuticals, Inc. insider buys or sells DCPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Deciphera Pharmaceuticals, Inc.

Track Activities on DCPH

Account